Evidence mapPaperPMID 34360574Full record

ReviewInternational journal of molecular sciences2021

Gasotransmitters for the Therapeutic Prevention of Hypertension and Kidney Disease.

Chien-Ning Hsu, You-Lin Tain

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. The NOS/NO System in Renal Programming and Reprogramming.Antioxidants (Basel, Switzerland) · 2023
    Review
  7. Diabetic Nephropathy and Gaseous Modulators.Antioxidants (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Article
  10. The Pathophysiology of HBiomolecules · 2022
    Review
  11. Article
  12. The First Thousand Days: Kidney Health and Beyond.Healthcare (Basel, Switzerland) · 2021
    Review
  13. Chronic Kidney Disease: Strategies to Retard Progression.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Chien-Ning HsuDepartment of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.ORCID 0000-0001-7470-528X
You-Lin TainDepartment of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.ORCID 0000-0002-7059-6407
Chang Gung University · TWKaohsiung Medical University · TW

Funding

Chang Gung Memorial Hospital, Kaohsiung, Taiwan CORPG8K0121, CORPG8J0121, CORPG8L0121, CORPG8L0261, and CORPG8L0301
6 · The paper itself

Abstract

Nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H

Indexed as

AnimalsGasotransmittersHumansHypertensionKidney DiseasesGasotransmittersasymmetric dimethylargininecarbon monoxidedevelopmental origins of health and disease (DOHaD)gasotransmitterheme oxygenasehydrogen sulfidehypertensionkidney diseasenitric oxide

Identifiers

PMID34360574
PMCPMC8345973
OpenAlexW3184273667

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.